Starpharma Holdings Ltd (SPHRF)
0.0774
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Starpharma Holdings Debt to Equity Ratio: 0.0908 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
December 31, 2023 | 0.0908 |
June 30, 2023 | 0.1372 |
December 31, 2022 | 0.1913 |
June 30, 2022 | 0.0827 |
December 31, 2021 | 0.0673 |
June 30, 2021 | 0.00 |
December 31, 2020 | 0.0215 |
June 30, 2020 | 0.00 |
December 31, 2019 | 0.0492 |
June 30, 2019 | 0.00 |
December 31, 2018 | 0.0005 |
June 30, 2018 | 0.00 |
December 31, 2017 | 0.0011 |
June 30, 2017 | 0.00 |
December 31, 2016 | 0.00 |
June 30, 2016 | 0.00 |
December 31, 2015 | 0.0006 |
June 30, 2015 | 0.00 |
December 31, 2014 | 0.0013 |
June 30, 2014 | 0.00 |
Date | Value |
---|---|
December 31, 2013 | 0.0021 |
June 30, 2013 | 0.00 |
December 31, 2012 | 0.0023 |
June 30, 2012 | 0.00 |
December 31, 2011 | 0.0007 |
June 30, 2011 | 0.00 |
December 31, 2010 | 0.0037 |
June 30, 2010 | 0.00 |
December 31, 2009 | 0.0062 |
June 30, 2009 | 0.00 |
December 31, 2008 | 0.0154 |
June 30, 2008 | 0.00 |
December 31, 2007 | 0.0118 |
June 30, 2007 | 0.00 |
December 31, 2006 | 0.012 |
December 31, 2005 | 0.0201 |
June 30, 2005 | 0.00 |
December 31, 2004 | 0.0107 |
June 30, 2004 | 0.00 |
December 31, 2003 | 0.0151 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jun 2019
0.1913
Maximum
Dec 2022
0.064
Average
0.0582
Median
Debt to Equity Ratio Benchmarks
Alterity Therapeutics Ltd | -- |
Kazia Therapeutics Ltd | -- |
Immutep Ltd | -- |
Opthea Ltd | 0.00 |
Mesoblast Ltd | -- |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 29.93M |
Total Liabilities (Quarterly) | 6.459M |
Shareholders Equity (Quarterly) | 23.47M |
Current Ratio | 5.604 |
Net Debt Paydown Yield | 0.46% |